Clinical Trials Directory

Trials / Completed

CompletedNCT06124300

Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome

A Single Group Study to Evaluate the Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Rael · Industry
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This is a virtual single group study that will last 12 weeks. Participants will take 1 scoop of the female hormone balance supplement, and mix it with their drink of choice every morning. Questionnaires will be completed at baseline, 1 week, 2 weeks, 4 weeks, and 12 weeks

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFemale Hormone Balance SupplementThe product contains: Myo-Inositol D-Chiro Inositol Folic Acid Vitamin D Vitamin B12

Timeline

Start date
2023-08-30
Primary completion
2024-01-19
Completion
2024-01-19
First posted
2023-11-09
Last updated
2024-08-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06124300. Inclusion in this directory is not an endorsement.

Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome (NCT06124300) · Clinical Trials Directory